FDA Scrutiny Sends Hims & Hers Stock Plunging
:## Analysis of the Article 1. Core Topic: The article discusses the regulatory challenges facing Hims & Hers Health Inc. due to the FDA’s crackdown on compounded GLP-1 medications marketed for weight loss. It details the FDA’s warning about unapproved compounded drugs and the potential consequences for companies like hims & Hers that offer thes … Read more